Home » Topics » BioWorld

BioWorld
RSS

STOCKS RETURN TO EARLY JUNE LEVEL

Aug. 3, 1992

SYNTRO TO COLLABORATE ON LIVESTOCK VACCINES

Aug. 3, 1992

PHARMATEC GETS SBIR FOR ANASTHETIC AGENT

Aug. 3, 1992

WEST COAST BIOTECH CONFERENCES

Aug. 3, 1992

APPOINTMENTS AND ADVANCEMENTS

Aug. 3, 1992

BIOTECH STOCKS BOUNCE BACK

Aug. 2, 1992

DNAP TO TEST-MARKET TOMATO

Aug. 2, 1992

CALGENE CLONES REDUCTASE GENE

Aug. 2, 1992

SERAGEN LIKES VIEW FROM THE CLINIC

Aug. 2, 1992

SHAMAN RAISES $10 MILLION IN VC FINANCING

Aug. 2, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...